% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • fudfighter4 fudfighter4 Aug 12, 2013 1:15 PM Flag

    Bugseypug - Phase III success is great news

    Re your -

    "Had INSM released wonderfully GREAT news, we could have been much higher ..."

    - spare us your ridiculous attempts to fudge what has happened here. A Phase III success is always GREAT news for a development-stage biotech -

    Date - Open - High - Low - Close - Shares traded

    July 01 - 3.05 - 3.05 - 2.87 - 2.92 - 4,859,325
    July 08 - 2.65 - 2.67 - 2.25 - 2.39 - 7,129,992
    July 15 - 2.53 - 2.85 - 2.53 - 2.75 - 7,890,613

    July 20 - Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (GSK) today announced that BENLYSTA™ (belimumab, formerly LymphoStat-B®) met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE).

    July 22 - 14.50 - 14.83 - 13.35 - 14.05 - 33,920,750

    Isn't it about time you offered us a valuation calculation based upon projected use of Arikace? Your comments on this issue are of no value to other users of this forum unless you can support your repeated claims that the current market valuation is reasonable with something more tangible than hot air.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • FUD, as many have commented here, I too have no idea how to calculate our value. Why not ask Bo, or historian? These dudes seem to have their finger on the pulse of things.

      look, I live in the real world...not fantasy land. The value of the company is what it is selling for today...right now. If you have skin in the game, the value is what one can sell it for....right now. Of course, we are all speculating, right?

      I do think you have suggested a share price of up to $1,200....please correct me if I'm wrong. I just know this, it is what it whining about insider trading and me whining about hedge fund activity will not change anything....if so, don't you think it would have changed something by now?

      Perhaps you would be kind enough to give us your valuation and imeframe of such? You see, I'm an idiot about such specifics. I could use your help in determining what my percentage take will be. My buy price was $11.96.

    • Bugseypug - if you don't understand how to value INSM might I suggest you ask somebody who does to offer his calculation?

      Hubby just posted this -

      "so im guessing fud is now suggesting we would be at $30???? such a world they live in I didn't know existed"

      The multiple question marks tell us he has good reason to believe a share price of $30 is unrealistic at this point.

      He has me on Ignore. But knowing how well the two of you get on I'm sure he'd be receptive to a request from you for his valuation calculation.

      And I am absolutely CERTAIN you will not ask him :-)

11.81+0.47(+4.14%)4:00 PMEDT